Researchers Released Massive T Cell Genetic Map
Stanford Medicine and Gladstone Institutes scientists published a database of gene activity from 22 million human T cells.
Updated on Oct. 13, 2026 in Life Sciences

Live Poll
Do you trust that new genetic research will lead to better treatment options for the public?
Researchers from Stanford Medicine and the Gladstone Institutes have released a comprehensive dataset mapping gene activity in 22 million human T cells. This publicly available resource aims to help scientists identify new genetic targets for medical therapies.
Why it matters
The study offers a vital lookup table for understanding the genetic patterns linked to autoimmune diseases and immune cell abnormalities. By providing this detailed map, researchers have created a foundation for developing future treatments for immune system disorders.
The study involved using CRISPR to methodically dial down the activity of 12,748 individual genes to observe immune cell responses. Scientists employed the perturb-seq technique to sequence the genetic material following each specific genomic perturbation.
The players
Stanford Medicine
This academic medical center is a leading research institution involved in the co-development of the T cell dataset.
Gladstone Institutes
This independent research organization focuses on understanding and preventing disease through biomedical innovation.
The details
The research team analyzed T cells obtained from four human donors to create the high-resolution map. This systematic approach allows for a clearer understanding of how individual genes influence immune function and potential malfunctions.
Timeline
October 13, 2026: The dataset was officially published in the journal Cell.
The Big Picture
This discovery marks a significant leap in functional genomics by utilizing the perturb-seq technique at an unprecedented scale. It provides a new paradigm for mapping complex immune cell behaviors that were previously difficult to isolate and characterize.
This dataset provides a critical resource that could accelerate the development of personalized treatments for autoimmune conditions. In the future, this foundational data may lead to more effective therapies that precisely target immune cell abnormalities.
The takeaway
This research provides a massive, open-access library for scientists currently working to solve immune system failures. By sharing this data, the teams are enabling a more collaborative approach to identifying the root causes of autoimmune diseases.
Further reading
For more information on current biological research, visit the Life Sciences section.
Source note: This article includes information reported by News Center.
Live Poll
Do you trust that new genetic research will lead to better treatment options for the public?










